The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1

被引:44
作者
Axelson, H [1 ]
机构
[1] Lund Univ, Hosp MAS, Div Mol Med, Dept Lab Med, S-20502 Malmo, Sweden
关键词
neuroblastoma; basic helix-loop-helix; MASH-1; HASH-1; HES-1; Notch-1; differentiation;
D O I
10.1016/S0304-3835(03)00453-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroblastoma is a childhood tumor originating from cells of the developing sympathetic nervous system. The disease exhibits a remarkable phenotypic diversity reflected in the outcome, ranging from spontaneous regression to fatal disease. Mammalian achaete-scute homologue 1 (MASH-1 or HASH-1 in humans), a basic helix-loop-helix transcription (bHLH) factor, is transiently expressed in migrating sympatho-adrenal precursor cells. This gene, which is essential for proper development of the sympathetic nervous system, is expressed in a majority of primary neuroblastomas and neuroblastoma cell lines indicating an embryonal origin of the tumor. One important negative regulator of MASH-1 expression is the bHLH factor hairy and Enhancer of split homolog-1 (HES-1), which in turn is under positive control of the Notch signaling cascade. When neuroblastoma cells are induced to differentiate, as indicated by neuronal morphology and upregulation of neuronal marker genes. the HASH-1 expression is rapidly downregulated with a concomitant, transient upregulation of HES-1. Furthermore, a constitutively active form of Notch-1 inhibits induced differentiation of neuroblastoma cells. In this review, the role of the Notch-signaling cascade in neuroblastoma, with focus on the bHLH factors HASH-1 and HES-1, will be discussed. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [1] Notch signaling in cancer
    Allenspach, EJ
    Maillard, I
    Aster, JC
    Pear, WS
    [J]. CANCER BIOLOGY & THERAPY, 2002, 1 (05) : 466 - 476
  • [2] Aster JC, 1997, J BIOL CHEM, V272, P11336
  • [3] BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407
  • [4] Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
    Bown, N
    Cotterill, S
    Lastowska, M
    O'Neill, S
    Pearson, ADJ
    Plantaz, D
    Meddeb, M
    Danglot, G
    Brinkschmidt, C
    Christiansen, H
    Laureys, G
    Speleman, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) : 1954 - 1961
  • [5] AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE
    BRODEUR, GM
    SEEGER, RC
    SCHWAB, M
    VARMUS, HE
    BISHOP, JM
    [J]. SCIENCE, 1984, 224 (4653) : 1121 - 1124
  • [6] Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
    Brown, JM
    [J]. MOLECULAR MEDICINE TODAY, 2000, 6 (04): : 157 - 162
  • [7] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
    Caron, H
    vanSluis, P
    deKraker, J
    Bokkerink, J
    Egeler, M
    Laureys, G
    Slater, R
    Westerveld, A
    Voute, PA
    Versteeg, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) : 225 - 230
  • [8] Groucho/TLE family proteins and transcriptional repression
    Chen, GQ
    Courey, AJ
    [J]. GENE, 2000, 249 (1-2) : 1 - 16
  • [9] TAN-1, THE HUMAN HOMOLOG OF THE DROSOPHILA NOTCH GENE, IS BROKEN BY CHROMOSOMAL TRANSLOCATIONS IN T-LYMPHOBLASTIC NEOPLASMS
    ELLISEN, LW
    BIRD, J
    WEST, DC
    SORENG, AL
    REYNOLDS, TC
    SMITH, SD
    SKLAR, J
    [J]. CELL, 1991, 66 (04) : 649 - 661
  • [10] A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regulates the VEGF expression and is potentially involved in lung and vascular development
    Ema, M
    Taya, S
    Yokotani, N
    Sogawa, K
    Matsuda, Y
    FujiiKuriyama, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4273 - 4278